Wellcome-MRC Institute of Metabolic Science
About us
The Wellcome-MRC Institute of Metabolic Science-Metabolic Research Laboratories (IMS-MRL) and its embedded Medical Research Council (MRC) Metabolic Diseases Unit investigate the mechanisms through which metabolic health is maintained and how this is disturbed in disease. We seek to use that knowledge to aid better treatment and prevention of obesity, Type 2 diabetes and related endocrine and metabolic diseases.
IMS-MRL groups encompass skills in genetics, cell biology, cell signalling, neuroendocrinology, bioenergetics, human and animal physiology, experimental medicine and clinical trials.
Training graduate students for a scientific career is a priority at the IMS-MRL. We have a mixture of both basic science students and clinical trainees and aim to provide everyone with a supportive, stimulating research and learning environment.
The IMS-MRL is the base for the MRC Metabolic Diseases Unit which supports four programmes of research that aim to improve understanding of the mechanisms responsible for obesity and related metabolic diseases.
Together with a Wellcome Strategic Award, it also supports core scientific facilities that underpin basic and experimental science at the IMS-MRL.
COVID-19
We continue to follow Government and University of Cambridge guidelines for staying COVID-safe.
Equality, diversity, inclusion and wellbeing
We aspire to be a place where everyone feels welcome, included, safe and heard.
Videos
Skinny genes – the genetics behind body weight
Why does obesity make COVID-19 more dangerous?
Live from the lab – do you want to see what it’s like to work in our Institute? Four short films for young people
News
Upcoming Events
Professor Alex Banks, Beth Israel Deaconess Medical Center, Harvard Medical School, USA – Next-Generation Methods In Preclinical Obesity Research
January 31 @ 1:15 pm - 2:15 pmProfessor Peter Shepherd, Maurice Wilkins Centre for Molecular Biodiscovery, Auckland, NZ – “Developing precision medicine strategies for metabolic disease in Māori and Pacific peoples by targeting population specific genetic variants”
February 2 @ 12:15 pm - 1:15 pmDr Ben Jones, Department of Metabolism, Digestion and Reproduction, Imperial College, London – Tissue-specific biased agonism in metabolic disease
February 7 @ 1:15 pm - 2:15 pm
